US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist

2.320
+0.025+1.09%

Close Jul 22 16:00 ET

2.210
-0.110-4.74%

Pre 08:00 ET

209.54MMarket Cap-1681P/E (TTM)

Caribou Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-33.16%-37.2M

-2.56%-93.29M

14.63%-21.38M

-28.66%-28.79M

30.58%-15.19M

-28.91%-27.94M

-179.73%-90.97M

-17.09%-25.04M

-49.50%-22.38M

-32.76%-21.87M

Net income from continuing operations

-47.03%-41.23M

-2.66%-102.07M

-27.85%-34.51M

62.46%-10M

-10.57%-29.52M

-46.92%-28.04M

-48.56%-99.42M

-46.05%-26.99M

-27.05%-26.65M

-86.55%-26.7M

Operating gains losses

----

---34K

--0

---34K

----

Depreciation and amortization

20.54%710K

117.32%3.53M

46.25%740K

250.89%1.58M

72.35%617K

91.23%589K

64.84%1.62M

85.35%506K

73.08%450K

55.65%358K

Other non cash items

561.92%1.72M

21,933.33%3.28M

415.48%2.18M

-70.12%666K

151.37%169K

121.24%260K

-100.62%-15K

67.98%-691K

-7.24%2.23M

-122.07%-329K

Change In working capital

64.06%-849K

-74.07%-7.32M

4,025.00%5.02M

-3,021.50%-22.07M

595.17%12.09M

53.76%-2.36M

-114.46%-4.2M

95.18%-128K

-129.35%-707K

159.94%1.74M

-Change in receivables

236.87%245K

-76.73%805K

284.94%1.28M

-294.42%-1.39M

238.46%1.1M

-108.58%-179K

216.77%3.46M

198.52%332K

15.27%717K

112.59%325K

-Change in prepaid assets

-141.86%-758K

281.13%1.77M

43.26%914K

-18.80%-1.5M

-42.57%545K

239.74%1.81M

75.88%-975K

149.69%638K

-38.06%-1.27M

174.14%949K

-Change in payables and accrued expense

119.58%516K

1,084.64%7.56M

306.85%3.63M

197.82%2.33M

84.17%4.25M

44.46%-2.64M

-114.17%-768K

414.84%891K

-78.68%781K

222.92%2.31M

-Change in other current assets

-437.10%-209K

91.49%-48K

91.13%-18K

-325.71%-149K

-64.60%57K

112.73%62K

-78.48%-564K

-23.03%-203K

---35K

-40.37%161K

-Change in other current liabilities

115.79%51K

-52.39%-637K

-179.03%-346K

326.80%220K

-80.77%-188K

-247.31%-323K

-158.02%-418K

11.43%-124K

-1,112.50%-97K

-1,633.33%-104K

-Change in other working capital

36.74%-694K

-239.46%-16.77M

74.19%-429K

-2,572.61%-21.57M

433.40%6.33M

-91.78%-1.1M

-115.87%-4.94M

-271.81%-1.66M

15.14%-807K

-173.77%-1.9M

Cash from discontinued investing activities

Operating cash flow

-33.16%-37.2M

-2.56%-93.29M

14.63%-21.38M

-28.66%-28.79M

30.58%-15.19M

-28.91%-27.94M

-179.73%-90.97M

-17.09%-25.04M

-49.50%-22.38M

-32.76%-21.87M

Investing cash flow

Cash flow from continuing investing activities

10.88%22.96M

26.88%-68.18M

-2,790.09%-31.47M

-721.15%-68.48M

179.18%11.06M

128.71%20.7M

47.14%-93.25M

100.67%1.17M

-332.07%-8.34M

-2,786.98%-13.97M

Net PPE purchase and sale

28.71%-1.45M

-79.93%-11.61M

-29.60%-2.28M

-250.96%-4.75M

2.56%-2.55M

-180.91%-2.03M

-204.29%-6.45M

-156.50%-1.76M

-45.59%-1.35M

-441.32%-2.62M

Net intangibles purchase and sale

---1.5M

--0

----

--0

40.00%-600K

---300K

----

Net investment purchase and sale

13.94%25.9M

34.37%-56.57M

-1,004.77%-29.2M

-853.24%-63.72M

219.94%13.62M

131.85%22.73M

50.26%-86.2M

101.86%3.23M

---6.69M

---11.35M

Cash from discontinued investing activities

Investing cash flow

10.88%22.96M

26.88%-68.18M

-2,790.09%-31.47M

-721.15%-68.48M

179.18%11.06M

128.71%20.7M

47.14%-93.25M

100.67%1.17M

-332.07%-8.34M

-2,786.98%-13.97M

Financing cash flow

Cash flow from continuing financing activities

660.35%12.49M

7,133.85%154.3M

-133.86%-43K

20,561.77%135.13M

4,753.87%17.57M

65.86%1.64M

-99.51%2.13M

-72.39%127K

-99.80%654K

-40.26%362K

Net common stock issuance

908.82%11.33M

--152.72M

---113K

--134.38M

--17.34M

--1.12M

--0

Proceeds from stock option exercised by employees

122.74%1.16M

-26.02%1.58M

-44.88%70K

15.14%753K

-34.81%236K

-47.58%519K

-16.39%2.13M

-72.39%127K

-31.95%654K

-36.04%362K

Cash from discontinued financing activities

Financing cash flow

660.35%12.49M

7,133.85%154.3M

-133.86%-43K

20,561.77%135.13M

4,753.87%17.57M

65.86%1.64M

-99.51%2.13M

-72.39%127K

-99.80%654K

-40.26%362K

Net cash flow

Beginning cash position

-12.29%51.21M

-75.72%58.38M

26.75%104.1M

-40.96%66.24M

-64.25%52.79M

-75.72%58.38M

1,407.34%240.47M

-81.13%82.13M

-13.41%112.19M

1.20%147.68M

Current changes in cash

68.50%-1.76M

96.06%-7.18M

-122.75%-52.9M

225.96%37.86M

137.90%13.45M

93.97%-5.59M

-181.10%-182.08M

87.82%-23.75M

-109.83%-30.06M

-116.97%-35.48M

End cash Position

-6.33%49.45M

-12.29%51.21M

26.75%104.1M

-40.96%66.24M

-64.25%52.79M

-75.72%58.38M

-81.13%82.13M

-13.41%112.19M

Free cash flow

-33.97%-40.15M

-7.02%-104.9M

12.71%-23.66M

-39.58%-33.54M

27.58%-17.74M

-33.82%-29.97M

-175.03%-98.02M

-22.77%-27.1M

-42.21%-24.03M

-44.42%-24.49M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-33.16%-37.2M	-2.56%-93.29M	14.63%-21.38M	-28.66%-28.79M	30.58%-15.19M	-28.91%-27.94M	-179.73%-90.97M	-17.09%-25.04M	-49.50%-22.38M	-32.76%-21.87M
Net income from continuing operations	-47.03%-41.23M	-2.66%-102.07M	-27.85%-34.51M	62.46%-10M	-10.57%-29.52M	-46.92%-28.04M	-48.56%-99.42M	-46.05%-26.99M	-27.05%-26.65M	-86.55%-26.7M
Operating gains losses	----	---34K	--0	--0	--0	---34K	----	----	----	----
Depreciation and amortization	20.54%710K	117.32%3.53M	46.25%740K	250.89%1.58M	72.35%617K	91.23%589K	64.84%1.62M	85.35%506K	73.08%450K	55.65%358K
Other non cash items	561.92%1.72M	21,933.33%3.28M	415.48%2.18M	-70.12%666K	151.37%169K	121.24%260K	-100.62%-15K	67.98%-691K	-7.24%2.23M	-122.07%-329K
Change In working capital	64.06%-849K	-74.07%-7.32M	4,025.00%5.02M	-3,021.50%-22.07M	595.17%12.09M	53.76%-2.36M	-114.46%-4.2M	95.18%-128K	-129.35%-707K	159.94%1.74M
-Change in receivables	236.87%245K	-76.73%805K	284.94%1.28M	-294.42%-1.39M	238.46%1.1M	-108.58%-179K	216.77%3.46M	198.52%332K	15.27%717K	112.59%325K
-Change in prepaid assets	-141.86%-758K	281.13%1.77M	43.26%914K	-18.80%-1.5M	-42.57%545K	239.74%1.81M	75.88%-975K	149.69%638K	-38.06%-1.27M	174.14%949K
-Change in payables and accrued expense	119.58%516K	1,084.64%7.56M	306.85%3.63M	197.82%2.33M	84.17%4.25M	44.46%-2.64M	-114.17%-768K	414.84%891K	-78.68%781K	222.92%2.31M
-Change in other current assets	-437.10%-209K	91.49%-48K	91.13%-18K	-325.71%-149K	-64.60%57K	112.73%62K	-78.48%-564K	-23.03%-203K	---35K	-40.37%161K
-Change in other current liabilities	115.79%51K	-52.39%-637K	-179.03%-346K	326.80%220K	-80.77%-188K	-247.31%-323K	-158.02%-418K	11.43%-124K	-1,112.50%-97K	-1,633.33%-104K
-Change in other working capital	36.74%-694K	-239.46%-16.77M	74.19%-429K	-2,572.61%-21.57M	433.40%6.33M	-91.78%-1.1M	-115.87%-4.94M	-271.81%-1.66M	15.14%-807K	-173.77%-1.9M
Cash from discontinued investing activities
Operating cash flow	-33.16%-37.2M	-2.56%-93.29M	14.63%-21.38M	-28.66%-28.79M	30.58%-15.19M	-28.91%-27.94M	-179.73%-90.97M	-17.09%-25.04M	-49.50%-22.38M	-32.76%-21.87M
Investing cash flow
Cash flow from continuing investing activities	10.88%22.96M	26.88%-68.18M	-2,790.09%-31.47M	-721.15%-68.48M	179.18%11.06M	128.71%20.7M	47.14%-93.25M	100.67%1.17M	-332.07%-8.34M	-2,786.98%-13.97M
Net PPE purchase and sale	28.71%-1.45M	-79.93%-11.61M	-29.60%-2.28M	-250.96%-4.75M	2.56%-2.55M	-180.91%-2.03M	-204.29%-6.45M	-156.50%-1.76M	-45.59%-1.35M	-441.32%-2.62M
Net intangibles purchase and sale	---1.5M	--0	--0	----	----	--0	40.00%-600K	---300K	----	----
Net investment purchase and sale	13.94%25.9M	34.37%-56.57M	-1,004.77%-29.2M	-853.24%-63.72M	219.94%13.62M	131.85%22.73M	50.26%-86.2M	101.86%3.23M	---6.69M	---11.35M
Cash from discontinued investing activities
Investing cash flow	10.88%22.96M	26.88%-68.18M	-2,790.09%-31.47M	-721.15%-68.48M	179.18%11.06M	128.71%20.7M	47.14%-93.25M	100.67%1.17M	-332.07%-8.34M	-2,786.98%-13.97M
Financing cash flow
Cash flow from continuing financing activities	660.35%12.49M	7,133.85%154.3M	-133.86%-43K	20,561.77%135.13M	4,753.87%17.57M	65.86%1.64M	-99.51%2.13M	-72.39%127K	-99.80%654K	-40.26%362K
Net common stock issuance	908.82%11.33M	--152.72M	---113K	--134.38M	--17.34M	--1.12M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	122.74%1.16M	-26.02%1.58M	-44.88%70K	15.14%753K	-34.81%236K	-47.58%519K	-16.39%2.13M	-72.39%127K	-31.95%654K	-36.04%362K
Cash from discontinued financing activities
Financing cash flow	660.35%12.49M	7,133.85%154.3M	-133.86%-43K	20,561.77%135.13M	4,753.87%17.57M	65.86%1.64M	-99.51%2.13M	-72.39%127K	-99.80%654K	-40.26%362K
Net cash flow
Beginning cash position	-12.29%51.21M	-75.72%58.38M	26.75%104.1M	-40.96%66.24M	-64.25%52.79M	-75.72%58.38M	1,407.34%240.47M	-81.13%82.13M	-13.41%112.19M	1.20%147.68M
Current changes in cash	68.50%-1.76M	96.06%-7.18M	-122.75%-52.9M	225.96%37.86M	137.90%13.45M	93.97%-5.59M	-181.10%-182.08M	87.82%-23.75M	-109.83%-30.06M	-116.97%-35.48M
End cash Position	-6.33%49.45M	-12.29%51.21M	-12.29%51.21M	26.75%104.1M	-40.96%66.24M	-64.25%52.79M	-75.72%58.38M	-75.72%58.38M	-81.13%82.13M	-13.41%112.19M
Free cash flow	-33.97%-40.15M	-7.02%-104.9M	12.71%-23.66M	-39.58%-33.54M	27.58%-17.74M	-33.82%-29.97M	-175.03%-98.02M	-22.77%-27.1M	-42.21%-24.03M	-44.42%-24.49M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall